Sam Brusco, Associate Editor01.21.21
Canon Medical Systems USA’s Aquilion Exceed LB CT system has earned FDA clearance, allowing healthcare professionals to observe more during radiation therapy planning in order to boost accuracy, precision, and speed. U.S. cancer cases continue to rise, and giving clinicians the most up-to-date technology for accurate simulation across treatment plans remains integral.
The Aquilion Exceed LB offers fast, efficient radiation oncology workflows without compromising on patient position, image quality, or reproducibility. Features include:
“The Aquilion Exceed LB was designed to push the boundaries of traditional simulation,” said Erin Angel, managing director, CT Business Unit, Canon Medical Systems USA. “Deep learning reconstruction will give radiation oncology teams the confidence they need for accurate and precise planning across patients.”
The Aquilion Exceed LB offers fast, efficient radiation oncology workflows without compromising on patient position, image quality, or reproducibility. Features include:
- Accuracy even in complex simulations through the industry’s largest bore opening (90 cm), edge-to-edge extended Field-of-View (90 cm) reconstruction, and wide detector coverage (4 cm).
- Better contouring powered by Artificial Intelligence (AI) with sharp, clear and distinct images from Canon Medical’s Advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR) technology.
- Exceed LB is also designed to meet the needs of radiology departments requiring flexibility to handle bariatric patients and challenging patient positioning, and with patient access and technology to streamline CT interventions.
“The Aquilion Exceed LB was designed to push the boundaries of traditional simulation,” said Erin Angel, managing director, CT Business Unit, Canon Medical Systems USA. “Deep learning reconstruction will give radiation oncology teams the confidence they need for accurate and precise planning across patients.”